Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,585 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: A retrospective exploratory study.
Sugimoto T, Atobe S, Kado Y, Takahashi A, Motoori M, Sugimura K, Miyata H, Yano M, Tanaka K, Doki Y, Shiraishi O, Yasuda T, Asahara T. Sugimoto T, et al. Among authors: doki y. J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001723. J Med Microbiol. 2023. PMID: 37367942 Clinical Trial.
Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial.
Toriumi T, Terashima M, Mizusawa J, Sato Y, Kurokawa Y, Takiguchi S, Doki Y, Shinohara H, Teshima S, Yasuda T, Ito S, Yoshikawa T, Sano T, Sasako M. Toriumi T, et al. Among authors: doki y. Eur J Surg Oncol. 2023 Apr;49(4):838-844. doi: 10.1016/j.ejso.2022.11.093. Epub 2022 Nov 16. Eur J Surg Oncol. 2023. PMID: 36424261 Clinical Trial.
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in Japan.
Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, Takeuchi H, Muto M, Kakeji Y, Kitagawa Y, Doki Y. Okamura A, et al. Among authors: doki y. Ann Surg Oncol. 2023 Apr;30(4):2176-2185. doi: 10.1245/s10434-022-12960-9. Epub 2022 Dec 17. Ann Surg Oncol. 2023. PMID: 36528742
[No title available]
[No authors listed] [No authors listed] PMID: 36602666
Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma.
Yamada M, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y. Yamada M, et al. Among authors: doki y. Oncol Lett. 2022 Dec 20;25(2):58. doi: 10.3892/ol.2022.13644. eCollection 2023 Feb. Oncol Lett. 2022. PMID: 36644140 Free PMC article.
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan.
Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, Takeuchi H, Muto M, Kakeji Y, Kitagawa Y, Doki Y. Okamura A, et al. Among authors: doki y. Esophagus. 2023 Jul;20(3):465-473. doi: 10.1007/s10388-023-01002-2. Epub 2023 Apr 8. Esophagus. 2023. PMID: 37029845
1,585 results